|
Volumn 23, Issue 6, 2014, Pages 993-1000
|
The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure
a b,c a |
Author keywords
Antihypertensive drugs; Blood pressure; Hypertension; Non steroidal anti inflammatory drugs
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
ANALGESIC AGENT;
ANGIOTENSIN II ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CELECOXIB;
DICLOFENAC;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FELODIPINE;
FLURBIPROFEN;
HYDROCHLOROTHIAZIDE PLUS LISINOPRIL;
IBUPROFEN;
INDOMETACIN;
LOOP DIURETIC AGENT;
NAPROXEN;
NIFEDIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PIROXICAM;
PROSTAGLANDIN;
PROSTAGLANDIN H2;
PROSTAGLANDIN SYNTHASE;
ROFECOXIB;
SULINDAC;
THIAZIDE DIURETIC AGENT;
THROMBOXANE A2;
TIAPROFENIC ACID;
ANTIHYPERTENSIVE THERAPY;
ARTHRALGIA;
BACKACHE;
BLOOD PRESSURE;
BLOOD PRESSURE REGULATION;
ELEVATED BLOOD PRESSURE;
HEART OUTPUT;
HUMAN;
HYPERTENSION;
REVIEW;
SODIUM ABSORPTION;
VASODILATATION;
AGE;
CLASSIFICATION;
DRUG EFFECTS;
DRUG INTERACTION;
PAIN;
PATHOPHYSIOLOGY;
POLYPHARMACY;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT OUTCOME;
AGE FACTORS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
DRUG INTERACTIONS;
HUMANS;
HYPERTENSION;
PAIN;
POLYPHARMACY;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 84922632977
PISSN: 18995276
EISSN: 24512680
Source Type: Journal
DOI: 10.17219/acem/37357 Document Type: Review |
Times cited : (21)
|
References (5)
|